Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOV-002 in Combination With Paclitaxel and Carboplatin for Advanced NSCLC
NCT00347412Phase 3Completed
- Sponsor
- Cellectar Biosciences
- Start
- Nov 2006
- Primary completion
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of glutathione disulfide in non-small cell lung cancer (NSCLC), sponsored by Cellectar Biosciences. Started Nov 2006; status: completed.
02
Drugs
glutathione disulfide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00347412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00347412.